The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the pharmaceutical industry. But the pharma industry’s gain is the food industry’s loss. Read more...
Site référencé: Quartz
weight loss, morgan stanley, anti obesity medication, health medical pharma, glp 1 receptor agonists, ozempic, glucagon like peptide 1, peptide therapeutics, glp 1, smithfield foods, sc johnson, semaglutide, obesity, wegovy, novo nordisk, peptide hormones, anti diabetic drugs, shane smith, social issues, addiction
Quartz
Higher prices, falling incomes : A Fed governor says the tariff pain isn't over yet
12/05/2025
Trump says he spoke to Apple CEO Tim Cook after announcing the tariffs pause
12/05/2025
The Trump family's crypto company is going public
12/05/2025
Trump's push for lower drug prices is just asking Big Pharma to make less money
12/05/2025
More U.S. airports could face chaos like Newark's meltdown, transportation chief warns
12/05/2025
Eli Lilly stock sinks as pharma misses out on the market rally
12/05/2025
